THREEVEN PHARMACEUTICAL PRIVATE LIMITED
THREEVEN PHARMACEUTICAL PRIVATE LIMITED is a MAHARASHTRA based PRIVATE LIMITED company, Registered at dated 14-MAY-2024 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of THREEVEN PHARMACEUTICAL PRIVATE LIMITED is U21002PN2024PTC230917 and registration number is 230917.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC PUNE India. Authorized share capital of THREEVEN PHARMACEUTICAL PRIVATE LIMITED is Rs. 100000 and its paid up capital is Rs. 100000. It aspire to serve in NA activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
THREEVEN PHARMACEUTICAL PRIVATE LIMITED has 2 directors PRATIK PRAKASH BIRDAWADE, RUPALI HEMRAJ PAWAR,
The registered Email address of THREEVEN PHARMACEUTICAL PRIVATE LIMITED is wholepharmaceutical@gmail.com and its registered address is GAT NO 452/1/1 INDRALOK COLONY MOSHI HAVELI PUNE MH 412105 IN MAHARASHTRA MAHARASHTRA india 412105.
The current status of THREEVEN PHARMACEUTICAL PRIVATE LIMITED shows as NOT AVAILABLE FOR EFILING
COMPANY BASIC DETAILS
THREEVEN PHARMACEUTICAL PRIVATE LIMITED
ROC PUNE
NOT AVAILABLE FOR EFILING
U21002PN2024PTC230917
14-MAY-2024
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
100000
100000
CONTACT DETAILS
412105
INDIA
GAT NO 452/1/1 INDRALOK COLONY MOSHI HAVELI PUNE MH 412105 IN
wholepharmaceutical@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
10627500 | PRATIK PRAKASH BIRDAWADE | Director | 14/05/2024 |
10627501 | RUPALI HEMRAJ PAWAR | Director | 14/05/2024 |
Details Updated by Companies
Quick Links
- All Registered company of MAHARASHTRA
- Company Registered in MAHARASHTRA
- All Registered company of PUNE in MAHARASHTRA
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.